BridgeMD
New treatment option for Preeclampsia
Official title Aspirin Discontinuation in High-Risk Pregnant Women of Preeclampsia
ClinicalTrials.gov ID: NCT06111079
What this study is testing
What is aspirin discontinuation?
aspirin discontinuation is an investigational medicine, being studied as a potential treatment for preeclampsia.
Also referred to as initiation of aspirin in early pregnancy.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Low-dose aspirin (LDA) is considered to be the most effective agent to prevent preeclampsia (PE). At present, there is little exploration about the timing of aspirin discontinuation.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- At \<16 weeks of gestation, normal NT scan
- At least 1 high risk factor or at least 2 moderate risk factors
- Intend to receive prenatal examination and deliver in this institution
- Signed a written informed consent for participation in the study
You likely can't join if
- Aspirin initiated after 16 week
- Intolerant or allergic to aspirin
- Aspirin adherence was \<80%
- Miscarriage or termination of pregnancy before randomization
- drop out (do not return to the hospital for delivery).
- Lost to follow-up
The study team makes the final eligibility decision.
Where it's taking place
- Guangzhou, Guangdong, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Guangzhou, Guangdong, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.